Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

AVALON PHARMACEUTICALS INC (AVRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.55 Metrics
OS: 20.4 M -1488 % ROE
Market cap: $11.2 M -735 % ROIC
Net debt: $542 k
EV: $11.8 M

 
TTM Valuation
EBITDA ($16.1) M
EBIT ($17.6) M
EPS ($1.08)

Recent News + Filings   (All items)
Date FiledTypeDescription
02/16/2010 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2010 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019133
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019131
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019129
07/01/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-06-30 Registration Form: POS AM Reference AccNo: 0000950123-09-019128
06/30/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement


Financial Summary   (All financials)
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues15.816.116.017.312.612.612.8
            Revenue growth-2.2%0.9%-7.7%37.8%-0.2%-1.7% 
Cost of goods sold15.515.313.315.810.712.512.8
Gross profit0.30.82.71.51.90.10.0
            Gross margin2.0%5.0%17.0%8.9%15.1%0.8%0.0%
General and administrative5.38.27.75.14.34.64.4
EBIT-20.4-22.8-18.2-19.3-13.1-17.0-17.3
            EBIT margin-129.4%-141.1%-113.8%-111.4%-104.2%-134.6%-134.6%
Pre-tax income-21.8-21.7-17.1-19.3-13.7-17.1-16.2
Income taxes0.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-21.8-21.7-17.1-19.3-13.7-17.1-16.2
            Net margin-138.4%-134.4%-106.9%-111.3%-108.6%-135.4%-125.9%
 
Diluted EPS($1.24)($1.42)($1.74)($0.01)($0.11)($0.13)($0.13)
Shares outstanding (diluted)17.615.39.82,129.4128.4126.6125.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy